Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Astrid Lièvre

Showing results (1-10 of 137) with videos related to

Pageof 14
Sort By:
The Lancet. Gastroenterology & Hepatology|February 3, 2022
Anti-PD-1 for pretreated advanced anal carcinoma: which patients will benefit?Astrid Lièvre
Gastroenterologie Clinique Et Biologique|March 2, 2005
[Mitochondrial DNA mutations and colorectal cancer]Astrid Lièvre, Pierre Laurent-Puig
Therapie|June 22, 2007
[Predictive factors in the response of antiplatelet anti EFGR in gastro-intestinal tumor]Pierre-Laurent Puig, Astrid Lièvre
Bulletin Du Cancer|January 31, 2008
[Predictive factors of response to anti-EGFR treatments in colorectal cancer]Astrid Lièvre, Pierre Laurent-Puig
La Revue Du Praticien|April 17, 2004
[Colorectal carcinogenesis: update]Astrid Lièvre, Pierre Laurent-Puig
Nature Reviews. Clinical Oncology|June 2, 2009
Genetics: Predictive value of KRAS mutations in chemoresistant CRCAstrid Lièvre, Pierre Laurent-Puig
Personalized Medicine|May 24, 2018
Toward an individualizing therapy for colorectal cancer: the example of the anti-EGFR monoclonal antibodiesAstrid Lièvre, Pierre Laurent-Puig
La Revue Du Praticien|January 5, 2011
[Biology applied to cancer treatments: the example of colorectal cancer]Astrid Lièvre, Pierre Laurent-Puig
Bulletin Du Cancer|December 19, 2022
Matthieu Delaye, Astrid Lièvre, Cindy Neuzillet
Asia-Pacific Journal of Oncology Nursing|July 21, 2025
The role of aerobic and resistance exercise for cancer cachexia management - A systematic scoping reviewRomane Peyrachon, Astrid Lièvre, Amélie Rébillard
Pageof 14

Showing results (1-10 of 137) with videos related to

Sort By:
Pageof 14
The Lancet. Gastroenterology & Hepatology|February 3, 2022
Anti-PD-1 for pretreated advanced anal carcinoma: which patients will benefit?Astrid Lièvre
Gastroenterologie Clinique Et Biologique|March 2, 2005
[Mitochondrial DNA mutations and colorectal cancer]Astrid Lièvre, Pierre Laurent-Puig
Therapie|June 22, 2007
[Predictive factors in the response of antiplatelet anti EFGR in gastro-intestinal tumor]Pierre-Laurent Puig, Astrid Lièvre
Bulletin Du Cancer|January 31, 2008
[Predictive factors of response to anti-EGFR treatments in colorectal cancer]Astrid Lièvre, Pierre Laurent-Puig
La Revue Du Praticien|April 17, 2004
[Colorectal carcinogenesis: update]Astrid Lièvre, Pierre Laurent-Puig
Nature Reviews. Clinical Oncology|June 2, 2009
Genetics: Predictive value of KRAS mutations in chemoresistant CRCAstrid Lièvre, Pierre Laurent-Puig
Personalized Medicine|May 24, 2018
Toward an individualizing therapy for colorectal cancer: the example of the anti-EGFR monoclonal antibodiesAstrid Lièvre, Pierre Laurent-Puig
La Revue Du Praticien|January 5, 2011
[Biology applied to cancer treatments: the example of colorectal cancer]Astrid Lièvre, Pierre Laurent-Puig
Bulletin Du Cancer|December 19, 2022
Matthieu Delaye, Astrid Lièvre, Cindy Neuzillet
Asia-Pacific Journal of Oncology Nursing|July 21, 2025
The role of aerobic and resistance exercise for cancer cachexia management - A systematic scoping reviewRomane Peyrachon, Astrid Lièvre, Amélie Rébillard
Pageof 14